| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/20/2005 | US20050014147 Method and apparatus for three label microarrays |
| 01/20/2005 | US20050014144 Prediciting strobilurin resistance in fungi via presence of polymorphic sequences in cytochrome b gene; allele specific oligonucleotide hybridization and nucleotide sequence amplification |
| 01/20/2005 | US20050014141 Expression vector comprising nucleotide sequences coding transport protein for use as tool in identifying modulators for treatment of cardiac and nervous system disorders; drug screening |
| 01/20/2005 | US20050014139 Human cyclin I and genes encoding same |
| 01/20/2005 | US20050014027 Crosslinked polymer doped with iron oxide; diagnosis of nucleic acids |
| 01/20/2005 | US20050013864 In situ administering; mixture of bone morphogenic protein and ethylene oxide-propylene oxide copolymer |
| 01/20/2005 | US20050013855 siRNA associated with lipid precipitate; in vivo delivery to cytosol |
| 01/20/2005 | US20050013827 Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof |
| 01/20/2005 | US20050013826 Administering modified protein having disruptive element located in internal region; enhancing ubiquitin proteasome system degradation; effective, long term T cell response |
| 01/20/2005 | US20050013825 Vaccine containing the catalytic subunit of telomerase for treating cancer |
| 01/20/2005 | US20050013824 Use of highly Immunodominant central nervous system myelin protein; inducing tolerance |
| 01/20/2005 | US20050013815 Prevention and treatment of amyloidogenic disease |
| 01/20/2005 | US20050013808 Nitroreductase enzymes |
| 01/20/2005 | US20050013796 Detection and treatment of breast disease |
| 01/20/2005 | DE19725371B4 Verfahren zur Beschleunigung der evolutiven Optimierung von Biopolymeren und zur Verbesserung der damit hergestellten Biopolymere A method for accelerating the evolutive optimization of biopolymers and improving the biopolymers produced therewith |
| 01/20/2005 | DE10330234A1 Verfahren zum Identifizieren von fungizid wirksamen Verbindungen basierend auf Mevalonat Kinasen aus Pilzen A method for identifying fungicidally active compounds based on mevalonate kinases from fungi |
| 01/20/2005 | CA2559791A1 Secreted proteins as markers for cell differentiation |
| 01/20/2005 | CA2534090A1 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 01/20/2005 | CA2532534A1 Methods for diagnosing endometriosis-related diseases |
| 01/20/2005 | CA2532173A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 01/20/2005 | CA2532150A1 Method of evaluating compound efficacious in treating obesity |
| 01/20/2005 | CA2532019A1 Sirna expression system |
| 01/20/2005 | CA2531962A1 Emitter-binding peptides that produce a change in the spectral emission properties of the emitter |
| 01/20/2005 | CA2531630A1 Glutamine:fructose-6-phosphate amidotransferase (gfat) comprising an internal purification marker and use thereof for the screening of compounds |
| 01/20/2005 | CA2531494A1 Method of screening for improved specific activity of enzymes |
| 01/20/2005 | CA2531235A1 Applications of a new class of enzymes: sulfiredoxines. |
| 01/20/2005 | CA2531222A1 Novel hcv core+1 protein, methods for diagnosis of hcv infections, prophylaxis, and for screening of anti-hcv agents |
| 01/20/2005 | CA2530994A1 Chloroplast transformation of duckweed |
| 01/20/2005 | CA2530967A1 Inhibition of stress-induced ligand-dependent egfr activation |
| 01/20/2005 | CA2530210A1 Non-inbred embryonic stem cells having good developmental potential |
| 01/20/2005 | CA2530029A1 Mutant adeno-associated virus virions and methods of use thereof |
| 01/20/2005 | CA2529509A1 Methods for the stereoselective synthesis and enantiomeric enrichment of .beta.-amino acids |
| 01/20/2005 | CA2529243A1 A method of selectively producing male or female sterile plants |
| 01/20/2005 | CA2527537A1 Modulation of c-reactive protein expression |
| 01/20/2005 | CA2527102A1 Packaged virus-like particles |
| 01/20/2005 | CA2524771A1 Non-human animals expressing heterologous complement receptor type 1 (cr1) molecules on erythrocytes and uses therefor |
| 01/19/2005 | EP1498497A2 Method of nucleic acid analysis by mass spectrometry |
| 01/19/2005 | EP1498496A2 DNA probe specific for Staphylococcus epidermidis |
| 01/19/2005 | EP1498495A2 DNA probe specific for Staphylococcus epidermidis |
| 01/19/2005 | EP1498494A2 Method of nucleic acid sequencing |
| 01/19/2005 | EP1498491A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO Fc GAMMA RECEPTOR IIIa |
| 01/19/2005 | EP1498490A1 Process for producing antibody composition |
| 01/19/2005 | EP1498489A2 Ascorbic acid production from yeasts |
| 01/19/2005 | EP1498487A1 Novel 35 kd protein |
| 01/19/2005 | EP1498486A1 Nucleic acid library and protein library |
| 01/19/2005 | EP1498481A1 Mutated subtilisin genes |
| 01/19/2005 | EP1498480A2 Human hydrolytic enzymes |
| 01/19/2005 | EP1498476A1 Mutated alkaline cellulase |
| 01/19/2005 | EP1498429A2 Rationally designed antibodies |
| 01/19/2005 | EP1498427A1 Immunoglobulins devoid of light chains |
| 01/19/2005 | EP1498426A1 Preparation of fully human antibodies |
| 01/19/2005 | EP1498145A1 DECOY FOR TREATING AND/OR PREVENTING Th2 CYTOKINE-ASSOCIATED ALLERGIC DISEASE, GATA3 MUTANT PROTEIN AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 01/19/2005 | EP1498129A1 Use of adenoviruses mutated in the va genes for cancer treatment |
| 01/19/2005 | EP1498027A1 Plant with improved organogenesis and method of constructing the same |
| 01/19/2005 | EP1497659A2 An ephrin-b receptor protein involved in carcinoma |
| 01/19/2005 | EP1497658A2 Protein involved in cancer |
| 01/19/2005 | EP1497656A2 Diagnosis of carcinoma using raig1 polypeptides |
| 01/19/2005 | EP1497655A1 Enhanced gene expression system |
| 01/19/2005 | EP1497643A1 Enclosed aquacultural systems for production of purified recombinant proteins |
| 01/19/2005 | EP1497634A2 Protein knobs |
| 01/19/2005 | EP1497470A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 01/19/2005 | EP1497468A1 Cells for detection of influenza and parainfluenza viruses |
| 01/19/2005 | EP1497467A2 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |
| 01/19/2005 | EP1497465A2 Constant length signatures for parallel sequencing of polynucleotides |
| 01/19/2005 | EP1497464A1 Compositions and methods related to two-arm nucleic acid probes |
| 01/19/2005 | EP1497463A1 Methods to predict patient responsiveness to tyrosine kinase inhibitors |
| 01/19/2005 | EP1497462A2 Genomic screen for epigenetically silenced genes associated with cancer |
| 01/19/2005 | EP1497458A2 Hydrophobic zone device |
| 01/19/2005 | EP1497457A1 Method and kit for detecting membrane protein-protein interactions |
| 01/19/2005 | EP1497455A2 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
| 01/19/2005 | EP1497454A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| 01/19/2005 | EP1497447A2 Ecist microarrays for dual screening of dna hypermethylation and gene silencing, and for use in an integrated system for assessing gene expression, dna methylation and histone acetylation |
| 01/19/2005 | EP1497444A2 Methods for increasing polypeptide production |
| 01/19/2005 | EP1497443A2 Methods for producing sulphurous fine chemicals by fermentation using meth-coding coryneform bacteria |
| 01/19/2005 | EP1497442A2 Biologic modulations with nanoparticles |
| 01/19/2005 | EP1497441A1 Synthetic transfer complex and method for transferring nucleic acids |
| 01/19/2005 | EP1497440A2 Stable adenoviral vectors and methods for propagation thereof |
| 01/19/2005 | EP1497439A2 Recombining viral vectors for the tetracycline-regulated expression of genes |
| 01/19/2005 | EP1497438A1 Means and methods for the production of adenovirus vectors |
| 01/19/2005 | EP1497437A2 Lentiviral vector particles resistant to complement inactivation |
| 01/19/2005 | EP1497436A1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolic disorders using such raav virons |
| 01/19/2005 | EP1497434A2 Matrix analysis of gene expression in cells (magec) |
| 01/19/2005 | EP1497433A2 Generation of plants with altered oil content |
| 01/19/2005 | EP1497432A2 Improved bacillus host cell |
| 01/19/2005 | EP1497431A2 Improved bacillus host cell |
| 01/19/2005 | EP1497430A2 Improved bacillus host cell |
| 01/19/2005 | EP1497429A2 Improved bacillus host cell |
| 01/19/2005 | EP1497428A2 Surface transfection and expression procedure |
| 01/19/2005 | EP1497427A2 Helicokinin-receptor from insects |
| 01/19/2005 | EP1497426A2 Co-stimulatory molecules |
| 01/19/2005 | EP1497425A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
| 01/19/2005 | EP1497424A1 Oligonucleotide compositions and their use for the modulation of immune responses |
| 01/19/2005 | EP1497423A2 Mcp-1 mutant proteins, antibodies, compositions, methods and uses |
| 01/19/2005 | EP1497422A2 La1 - the genome of a lactobacillus strain |
| 01/19/2005 | EP1497421A1 Novel 33 phage vectors |
| 01/19/2005 | EP1497419A1 Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof |
| 01/19/2005 | EP1497418A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 01/19/2005 | EP1497417A2 Epha2 antigen t epitopes |
| 01/19/2005 | EP1497415A2 Cytokine receptor |
| 01/19/2005 | EP1497413A1 Methods for producing immortalised antibodies-secreting cells |